Newsletter Regulatory – May 2017

NL Regulatory – May 2017

  • Medical devices – On your marks: ready?
  • Completion of the disclosure programme reform
  • Action for damages against anti-competitive practices: following group actions, the “distinction” of consumers
  • Action against supply shortage and product traceability : parallel trading at the center of discussions
  • Further clarification on importation and exportation of tissues, cells and cellular products for therapeutic use
  • Compulsory transmission to the ANSM of a summary of product characteristics for implantable and class III MDs